Research groups within DDB augment cell-based pharmacology with pre-clinical studies utilising native tissues and in vivo models of disease.
We have active collaborations with the pharmaceutical industry to identify novel drug targets and to test potential lead compounds, while the relationships between drug action, pharmacokinetics and pharmacodynamics are evaluated in collaboration with the Centre for Drug Candidate Optimisation at MIPS.
|Analytical Neuropharmacology||Cancer & Neural-Immune Regulation|
|Cardiac GPCR Pharmacology||Cellular & Molecular Metabolism|
|Male Reproductive Pharmacology||Metabolic GPCR Biology|
|Molecular & Translational Drug Discovery|